Plenary Session to discuss future of healthcare policy.
Share:
Press Release Summary:
BIO announced that former Senator John B. Breaux (D-LA) and former Congressman Jim McCrery III (R-LA) will be panelists at 13th Annual BIO CEO and Investor Conference. Moderated by BIO President and CEO, and former Congressman, James C. Greenwood, opening plenary session will offer discussion concerning future of healthcare policy under new Congress as interpreted by 3 healthcare policy experts. Panel will address questions concerning repeal efforts, recent court decisions, and implementation.
Original Press Release:
The Future of Healthcare Policy to be Plenary Discussion at 13th Annual BIO CEO & Investor Conference
Legislative Luminaries Discuss the Future Of Healthcare Policy Under A New Congress
WASHINGTON, D.C. -The Biotechnology Industry Organization (BIO) today announced that former Senator John B. Breaux (D-LA), former Member, Senate Finance Committee, along with former Congressman Jim McCrery III (R-LA), former Ranking Member, House Ways & Means Committee, will be panelists at the 13th Annual BIO CEO & Investor Conference.
Moderated by BIO President and Chief Executive Officer, and former Congressman, James C. Greenwood, this opening plenary session opening plenary session will offer a discussion concerning the future of healthcare policy under a new Congress as interpreted by three healthcare policy experts. Read more about the session and the panelists here.
The debate concerning public administration of healthcare shows no sign of abating and this panel will address significant questions concerning repeal efforts, recent court decisions and implementation.
The 13th Annual BIO CEO & Investor Conference provides a forum for institutional investors, research analysts and senior industry executives to discuss investment trends, attend company presentations, conduct one-on-one meetings, and learn about investment opportunities within the biotechnology industry. This event is the world's largest independent investor conference focused on publicly-traded biotechnology companies.
Media registration is complimentary for qualified investors and credentialed members of the media.
About the 13th Annual BIO CEO & Investor Conference
The BIO CEO & Investor Conference is a must attend event for institutional investors, industry analysts, and senior biotechnology executives focused on shaping the future investment landscape of the biotechnology industry.
BIO is pleased to recognize the leadership provided by the BIO CEO & Investor Conference sponsors, including Lead Bank Sponsor Wedbush PacGrow Life Sciences, Host Bank Sponsor Rodman & Renshaw LLC, and Supporting Bank Sponsors BMO Capital Markets, Deutsche Bank, Lazard and Roth Capital Partners.
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtech Now, an online portal and monthly newsletter chronicling "innovations transforming our world." Subscribe to BIOtech Now.
